Pregnancy in Women With HIV Infection
NCT04350554 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2020-07-14
Summary
Women living with HIV face multiple challenges regarding pregnancy, encompassing not only their intention to procreate, but also difficulties during the course of pregnancy.
Compared to HIV-negative controls, HIV-infected women have a higher risk of pregnancy complications such as preeclampsia, gestational diabetes, or preterm labor. In addition, the treatment of HIV among pregnant women entails specific difficulties, such as changes in bioavailability of antiretroviral drugs, or the concern about the association of certain antiretrovirals with adverse pregnancy outcomes.
There is very little evidence about pregnancy among women living with HIV in Spain. Very few studies have been published, performed in single centers or in small cohorts with a limited number of patients. The Cohort of the Spanish AIDS Research Network (CoRIS) offers a unique setting to answer questions that are unlikely to be answered by a single study.
The aims of this study are (i) to describe the incidence of pregnancies and their temporal trends from 2004 to 2019, (ii) o describe the clinical and epidemiological characteristics of women who become pregnant, (iii) to assess the diagnostic delay among women diagnosed with HIV infection after becoming pregnant, (iv) to investigate the clinical course during pregnancy and its predictive factors, (v) to describe the antiretroviral treatment administered to pregnant women, (vi) to describe clinical outcomes after pregnancy, (vii) to describe the outcome of the conception in terms of interrupted pregnancies, spontaneous abortions, term pregnancies, type of delivery (vaginal or caesarean section) and HIV infection of the newborn, and (vii) to evaluate attitudes towards pregnancy (ie. planned pregnancy) and social support among women who become pregnant during the year 2020.
Study population will be women from the cohort of the Spanish AIDS Research Network (CoRIS) who have become pregnant in the period 2004-2010.
Conditions
- HIV Infections
- Pregnancy Related
Interventions
- OTHER
-
Pregnancy
To measure and characterize pregnancies and describe the clinical course during pregnancy
- OTHER
-
Pregnancy
To evaluate attitudes towards pregnancy (ie. planned pregnancy) and social support among women who become pregnant during the year 2020
Sponsors & Collaborators
-
Red Temática de Investigación Cooperativa en Sida
collaborator UNKNOWN - collaborator INDUSTRY
-
Carlos III Health Institute
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2020-09-01
- Completion
- 2021-06-30
More Related Trials
-
Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
NCT00017797 ·Status: COMPLETED
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
NCT03284645 ·Status: COMPLETED
-
HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
NCT00393302 ·Status: COMPLETED
-
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
NCT02245022 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
NCT00639145 ·Status: COMPLETED
-
HIV Testing Strategies in the Perinatal Setting
NCT00503308 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Barriers to Postpartum Care in HIV Infected Women
NCT01853917 ·Status: COMPLETED
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPA
NCT03153709 ·Status: COMPLETED
-
Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth
NCT02970552 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life Related to the Care of Women Living With HIV During the Perinatal Period
NCT06666530 ·Status: RECRUITING
-
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000828 ·Status: COMPLETED
-
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT00404989 ·Status: RECRUITING
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women
NCT04900974 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
NCT01618305 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of HIV Levels During Pregnancy and After Childbirth
NCT00041964 ·Status: COMPLETED
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
NCT00100867 ·Status: COMPLETED
-
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
NCT04405700 ·Status: RECRUITING
-
A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
NCT01865786 ·Status: COMPLETED
-
Rapid HIV Tests for Women Late in Pregnancy and During Labor
NCT00046436 ·Status: TERMINATED
-
Dolutegravir in Pregnant HIV Mothers and Their Neonates
NCT03249181 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
NCT02738502 ·Status: COMPLETED ·Phase: PHASE2